Abbott, Reckitt and Mead Johnson

Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case
The Whitfield family legal case was just one of many still pending relating to the necrotizing enterocolitis (NEC) disease.
Abbott, Mead Johnson Win Defense Verdict Over Preemie Infant Formula
In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.
Abbott and Reckitt unit secure win in infant formula trial
Abbott and Reckitt's unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit that accused the companies of failing to warn of the risks of premature baby formulas.
Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win
Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case concerning its baby formulas.
Mead Johnson, Abbott Laboratories cleared in NEC trial
The infant formula manufacturers were facing $6.2bn in punitive damages over allegations their infant formula products caused a potentially life-threatening intestinal disease in a prematurely-born baby.
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness.
Abbott, Mead Johnson secure win in infant formula trial, Reuters reports
Abbott (ABT) and Reckitt Benckiser’s (RBGLY) unit Mead Johnson are not responsible for a young boy’s debilitating intestinal
Abbott, Reckitt Score First Victory in Baby Formula Trial
Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that severely sickened a baby boy.
Abbott shares rise after securing first win in premature infant formula trial
Abbott Laboratories shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature baby formulas' risks.
Tribune News Service on MSN13h
Hundreds of lawsuits allege Abbott Laboratories’ formula for premature infants made babies sick. But is the formula to blame?
To Dioselina Salto, the first two weeks of motherhood were amazing, even though she spent much of it in the hospital after ...
Abbott Laboratories’ Legal Victory Strengthens Future Outlook and Supports Buy Rating
Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...
Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win
The ruling by a Missouri state court jury is a rare legal win for Abbott Laboratories, maker of Similac formula, and ...
Jury sides with Abbott Laboratories in ongoing fight over preterm infant formulas
A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not ...